0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leukapheresis Products Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-18K5986
Home | Market Reports | Health| Nursing
Global Leukapheresis Products Market Insights Forecast to 2028
BUY CHAPTERS

Global Leukapheresis Products Market Research Report 2025

Code: QYRE-Auto-18K5986
Report
June 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Leukapheresis Products Market

The global market for Leukapheresis Products was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Leukapheresis Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Leukapheresis Products is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Leukapheresis Products include Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, ZENBIO, Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leukapheresis Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukapheresis Products.
The Leukapheresis Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leukapheresis Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukapheresis Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Leukapheresis Products Market Report

Report Metric Details
Report Name Leukapheresis Products Market
Segment by Type
  • Leukapheresis Disposables
  • Apheresis Devices
  • Leukoreduction Filters
Segment by Application
  • Therapeutic Applications
  • Research Applications
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Leukapheresis Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Leukapheresis Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Leukapheresis Products Market report?

Ans: The main players in the Leukapheresis Products Market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress

What are the Application segmentation covered in the Leukapheresis Products Market report?

Ans: The Applications covered in the Leukapheresis Products Market report are Therapeutic Applications, Research Applications

What are the Type segmentation covered in the Leukapheresis Products Market report?

Ans: The Types covered in the Leukapheresis Products Market report are Leukapheresis Disposables, Apheresis Devices, Leukoreduction Filters

1 Leukapheresis Products Market Overview
1.1 Product Definition
1.2 Leukapheresis Products by Type
1.2.1 Global Leukapheresis Products Market Value Comparison by Type (2024 VS 2031)
1.2.2 Leukapheresis Disposables
1.2.3 Apheresis Devices
1.2.4 Leukoreduction Filters
1.3 Leukapheresis Products by Application
1.3.1 Global Leukapheresis Products Market Value by Application (2024 VS 2031)
1.3.2 Therapeutic Applications
1.3.3 Research Applications
1.4 Global Leukapheresis Products Market Size Estimates and Forecasts
1.4.1 Global Leukapheresis Products Revenue 2020-2031
1.4.2 Global Leukapheresis Products Sales 2020-2031
1.4.3 Global Leukapheresis Products Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Leukapheresis Products Market Competition by Manufacturers
2.1 Global Leukapheresis Products Sales Market Share by Manufacturers (2020-2025)
2.2 Global Leukapheresis Products Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Leukapheresis Products Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Leukapheresis Products, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Leukapheresis Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Leukapheresis Products, Product Type & Application
2.7 Global Key Manufacturers of Leukapheresis Products, Date of Enter into This Industry
2.8 Global Leukapheresis Products Market Competitive Situation and Trends
2.8.1 Global Leukapheresis Products Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Leukapheresis Products Players Market Share by Revenue
2.8.3 Global Leukapheresis Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Leukapheresis Products Market Scenario by Region
3.1 Global Leukapheresis Products Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Leukapheresis Products Sales by Region: 2020-2031
3.2.1 Global Leukapheresis Products Sales by Region: 2020-2025
3.2.2 Global Leukapheresis Products Sales by Region: 2026-2031
3.3 Global Leukapheresis Products Revenue by Region: 2020-2031
3.3.1 Global Leukapheresis Products Revenue by Region: 2020-2025
3.3.2 Global Leukapheresis Products Revenue by Region: 2026-2031
3.4 North America Leukapheresis Products Market Facts & Figures by Country
3.4.1 North America Leukapheresis Products Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Leukapheresis Products Sales by Country (2020-2031)
3.4.3 North America Leukapheresis Products Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Leukapheresis Products Market Facts & Figures by Country
3.5.1 Europe Leukapheresis Products Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Leukapheresis Products Sales by Country (2020-2031)
3.5.3 Europe Leukapheresis Products Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leukapheresis Products Market Facts & Figures by Region
3.6.1 Asia Pacific Leukapheresis Products Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Leukapheresis Products Sales by Region (2020-2031)
3.6.3 Asia Pacific Leukapheresis Products Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Leukapheresis Products Market Facts & Figures by Country
3.7.1 Latin America Leukapheresis Products Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Leukapheresis Products Sales by Country (2020-2031)
3.7.3 Latin America Leukapheresis Products Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Leukapheresis Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Leukapheresis Products Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Leukapheresis Products Sales by Country (2020-2031)
3.8.3 Middle East and Africa Leukapheresis Products Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Leukapheresis Products Sales by Type (2020-2031)
4.1.1 Global Leukapheresis Products Sales by Type (2020-2025)
4.1.2 Global Leukapheresis Products Sales by Type (2026-2031)
4.1.3 Global Leukapheresis Products Sales Market Share by Type (2020-2031)
4.2 Global Leukapheresis Products Revenue by Type (2020-2031)
4.2.1 Global Leukapheresis Products Revenue by Type (2020-2025)
4.2.2 Global Leukapheresis Products Revenue by Type (2026-2031)
4.2.3 Global Leukapheresis Products Revenue Market Share by Type (2020-2031)
4.3 Global Leukapheresis Products Price by Type (2020-2031)
5 Segment by Application
5.1 Global Leukapheresis Products Sales by Application (2020-2031)
5.1.1 Global Leukapheresis Products Sales by Application (2020-2025)
5.1.2 Global Leukapheresis Products Sales by Application (2026-2031)
5.1.3 Global Leukapheresis Products Sales Market Share by Application (2020-2031)
5.2 Global Leukapheresis Products Revenue by Application (2020-2031)
5.2.1 Global Leukapheresis Products Revenue by Application (2020-2025)
5.2.2 Global Leukapheresis Products Revenue by Application (2026-2031)
5.2.3 Global Leukapheresis Products Revenue Market Share by Application (2020-2031)
5.3 Global Leukapheresis Products Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haemonetics
6.1.1 Haemonetics Company Information
6.1.2 Haemonetics Description and Business Overview
6.1.3 Haemonetics Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haemonetics Leukapheresis Products Product Portfolio
6.1.5 Haemonetics Recent Developments/Updates
6.2 Terumo BCT
6.2.1 Terumo BCT Company Information
6.2.2 Terumo BCT Description and Business Overview
6.2.3 Terumo BCT Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Terumo BCT Leukapheresis Products Product Portfolio
6.2.5 Terumo BCT Recent Developments/Updates
6.3 Asahi Kasei Medical
6.3.1 Asahi Kasei Medical Company Information
6.3.2 Asahi Kasei Medical Description and Business Overview
6.3.3 Asahi Kasei Medical Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Asahi Kasei Medical Leukapheresis Products Product Portfolio
6.3.5 Asahi Kasei Medical Recent Developments/Updates
6.4 STEMCELL Technologies
6.4.1 STEMCELL Technologies Company Information
6.4.2 STEMCELL Technologies Description and Business Overview
6.4.3 STEMCELL Technologies Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.4.4 STEMCELL Technologies Leukapheresis Products Product Portfolio
6.4.5 STEMCELL Technologies Recent Developments/Updates
6.5 Macopharma
6.5.1 Macopharma Company Information
6.5.2 Macopharma Description and Business Overview
6.5.3 Macopharma Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Macopharma Leukapheresis Products Product Portfolio
6.5.5 Macopharma Recent Developments/Updates
6.6 HemaCare Corporation
6.6.1 HemaCare Corporation Company Information
6.6.2 HemaCare Corporation Description and Business Overview
6.6.3 HemaCare Corporation Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HemaCare Corporation Leukapheresis Products Product Portfolio
6.6.5 HemaCare Corporation Recent Developments/Updates
6.7 Caltag Medsystem
6.7.1 Caltag Medsystem Company Information
6.7.2 Caltag Medsystem Description and Business Overview
6.7.3 Caltag Medsystem Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Caltag Medsystem Leukapheresis Products Product Portfolio
6.7.5 Caltag Medsystem Recent Developments/Updates
6.8 ALLCells
6.8.1 ALLCells Company Information
6.8.2 ALLCells Description and Business Overview
6.8.3 ALLCells Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ALLCells Leukapheresis Products Product Portfolio
6.8.5 ALLCells Recent Developments/Updates
6.9 ZENBIO
6.9.1 ZENBIO Company Information
6.9.2 ZENBIO Description and Business Overview
6.9.3 ZENBIO Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ZENBIO Leukapheresis Products Product Portfolio
6.9.5 ZENBIO Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Company Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Fresenius Kabi Leukapheresis Products Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 PPA Research Group
6.11.1 PPA Research Group Company Information
6.11.2 PPA Research Group Description and Business Overview
6.11.3 PPA Research Group Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.11.4 PPA Research Group Leukapheresis Products Product Portfolio
6.11.5 PPA Research Group Recent Developments/Updates
6.12 StemExpress
6.12.1 StemExpress Company Information
6.12.2 StemExpress Description and Business Overview
6.12.3 StemExpress Leukapheresis Products Sales, Revenue and Gross Margin (2020-2025)
6.12.4 StemExpress Leukapheresis Products Product Portfolio
6.12.5 StemExpress Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leukapheresis Products Industry Chain Analysis
7.2 Leukapheresis Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leukapheresis Products Production Mode & Process Analysis
7.4 Leukapheresis Products Sales and Marketing
7.4.1 Leukapheresis Products Sales Channels
7.4.2 Leukapheresis Products Distributors
7.5 Leukapheresis Products Customer Analysis
8 Leukapheresis Products Market Dynamics
8.1 Leukapheresis Products Industry Trends
8.2 Leukapheresis Products Market Drivers
8.3 Leukapheresis Products Market Challenges
8.4 Leukapheresis Products Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Leukapheresis Products Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Leukapheresis Products Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Leukapheresis Products Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Leukapheresis Products Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Leukapheresis Products Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Leukapheresis Products Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Leukapheresis Products Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Leukapheresis Products Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Leukapheresis Products, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Leukapheresis Products, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Leukapheresis Products, Product Type & Application
 Table 12. Global Key Manufacturers of Leukapheresis Products, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Leukapheresis Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukapheresis Products as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Leukapheresis Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Leukapheresis Products Sales by Region (2020-2025) & (K Units)
 Table 18. Global Leukapheresis Products Sales Market Share by Region (2020-2025)
 Table 19. Global Leukapheresis Products Sales by Region (2026-2031) & (K Units)
 Table 20. Global Leukapheresis Products Sales Market Share by Region (2026-2031)
 Table 21. Global Leukapheresis Products Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Leukapheresis Products Revenue Market Share by Region (2020-2025)
 Table 23. Global Leukapheresis Products Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Leukapheresis Products Revenue Market Share by Region (2026-2031)
 Table 25. North America Leukapheresis Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Leukapheresis Products Sales by Country (2020-2025) & (K Units)
 Table 27. North America Leukapheresis Products Sales by Country (2026-2031) & (K Units)
 Table 28. North America Leukapheresis Products Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Leukapheresis Products Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Leukapheresis Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Leukapheresis Products Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Leukapheresis Products Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Leukapheresis Products Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Leukapheresis Products Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Leukapheresis Products Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Leukapheresis Products Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Leukapheresis Products Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Leukapheresis Products Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Leukapheresis Products Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Leukapheresis Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Leukapheresis Products Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Leukapheresis Products Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Leukapheresis Products Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Leukapheresis Products Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Leukapheresis Products Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Leukapheresis Products Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Leukapheresis Products Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Leukapheresis Products Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Leukapheresis Products Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Leukapheresis Products Sales (K Units) by Type (2020-2025)
 Table 51. Global Leukapheresis Products Sales (K Units) by Type (2026-2031)
 Table 52. Global Leukapheresis Products Sales Market Share by Type (2020-2025)
 Table 53. Global Leukapheresis Products Sales Market Share by Type (2026-2031)
 Table 54. Global Leukapheresis Products Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Leukapheresis Products Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Leukapheresis Products Revenue Market Share by Type (2020-2025)
 Table 57. Global Leukapheresis Products Revenue Market Share by Type (2026-2031)
 Table 58. Global Leukapheresis Products Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Leukapheresis Products Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Leukapheresis Products Sales (K Units) by Application (2020-2025)
 Table 61. Global Leukapheresis Products Sales (K Units) by Application (2026-2031)
 Table 62. Global Leukapheresis Products Sales Market Share by Application (2020-2025)
 Table 63. Global Leukapheresis Products Sales Market Share by Application (2026-2031)
 Table 64. Global Leukapheresis Products Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Leukapheresis Products Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Leukapheresis Products Revenue Market Share by Application (2020-2025)
 Table 67. Global Leukapheresis Products Revenue Market Share by Application (2026-2031)
 Table 68. Global Leukapheresis Products Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Leukapheresis Products Price (US$/Unit) by Application (2026-2031)
 Table 70. Haemonetics Company Information
 Table 71. Haemonetics Description and Business Overview
 Table 72. Haemonetics Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Haemonetics Leukapheresis Products Product
 Table 74. Haemonetics Recent Developments/Updates
 Table 75. Terumo BCT Company Information
 Table 76. Terumo BCT Description and Business Overview
 Table 77. Terumo BCT Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Terumo BCT Leukapheresis Products Product
 Table 79. Terumo BCT Recent Developments/Updates
 Table 80. Asahi Kasei Medical Company Information
 Table 81. Asahi Kasei Medical Description and Business Overview
 Table 82. Asahi Kasei Medical Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Asahi Kasei Medical Leukapheresis Products Product
 Table 84. Asahi Kasei Medical Recent Developments/Updates
 Table 85. STEMCELL Technologies Company Information
 Table 86. STEMCELL Technologies Description and Business Overview
 Table 87. STEMCELL Technologies Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. STEMCELL Technologies Leukapheresis Products Product
 Table 89. STEMCELL Technologies Recent Developments/Updates
 Table 90. Macopharma Company Information
 Table 91. Macopharma Description and Business Overview
 Table 92. Macopharma Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Macopharma Leukapheresis Products Product
 Table 94. Macopharma Recent Developments/Updates
 Table 95. HemaCare Corporation Company Information
 Table 96. HemaCare Corporation Description and Business Overview
 Table 97. HemaCare Corporation Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HemaCare Corporation Leukapheresis Products Product
 Table 99. HemaCare Corporation Recent Developments/Updates
 Table 100. Caltag Medsystem Company Information
 Table 101. Caltag Medsystem Description and Business Overview
 Table 102. Caltag Medsystem Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Caltag Medsystem Leukapheresis Products Product
 Table 104. Caltag Medsystem Recent Developments/Updates
 Table 105. ALLCells Company Information
 Table 106. ALLCells Description and Business Overview
 Table 107. ALLCells Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. ALLCells Leukapheresis Products Product
 Table 109. ALLCells Recent Developments/Updates
 Table 110. ZENBIO Company Information
 Table 111. ZENBIO Description and Business Overview
 Table 112. ZENBIO Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. ZENBIO Leukapheresis Products Product
 Table 114. ZENBIO Recent Developments/Updates
 Table 115. Fresenius Kabi Company Information
 Table 116. Fresenius Kabi Description and Business Overview
 Table 117. Fresenius Kabi Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Fresenius Kabi Leukapheresis Products Product
 Table 119. Fresenius Kabi Recent Developments/Updates
 Table 120. PPA Research Group Company Information
 Table 121. PPA Research Group Description and Business Overview
 Table 122. PPA Research Group Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. PPA Research Group Leukapheresis Products Product
 Table 124. PPA Research Group Recent Developments/Updates
 Table 125. StemExpress Company Information
 Table 126. StemExpress Description and Business Overview
 Table 127. StemExpress Leukapheresis Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. StemExpress Leukapheresis Products Product
 Table 129. StemExpress Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Leukapheresis Products Distributors List
 Table 133. Leukapheresis Products Customers List
 Table 134. Leukapheresis Products Market Trends
 Table 135. Leukapheresis Products Market Drivers
 Table 136. Leukapheresis Products Market Challenges
 Table 137. Leukapheresis Products Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Leukapheresis Products
 Figure 2. Global Leukapheresis Products Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Leukapheresis Products Market Share by Type: 2024 & 2031
 Figure 4. Leukapheresis Disposables Product Picture
 Figure 5. Apheresis Devices Product Picture
 Figure 6. Leukoreduction Filters Product Picture
 Figure 7. Global Leukapheresis Products Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Leukapheresis Products Market Share by Application: 2024 & 2031
 Figure 9. Therapeutic Applications
 Figure 10. Research Applications
 Figure 11. Global Leukapheresis Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Leukapheresis Products Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Leukapheresis Products Sales (2020-2031) & (K Units)
 Figure 14. Global Leukapheresis Products Average Price (US$/Unit) & (2020-2031)
 Figure 15. Leukapheresis Products Report Years Considered
 Figure 16. Leukapheresis Products Sales Share by Manufacturers in 2024
 Figure 17. Global Leukapheresis Products Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Leukapheresis Products Players: Market Share by Revenue in Leukapheresis Products in 2024
 Figure 19. Leukapheresis Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Leukapheresis Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Leukapheresis Products Sales Market Share by Country (2020-2031)
 Figure 22. North America Leukapheresis Products Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Leukapheresis Products Sales Market Share by Country (2020-2031)
 Figure 26. Europe Leukapheresis Products Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Leukapheresis Products Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Leukapheresis Products Revenue Market Share by Region (2020-2031)
 Figure 34. China Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Leukapheresis Products Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Leukapheresis Products Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Leukapheresis Products Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Leukapheresis Products Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Leukapheresis Products Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Leukapheresis Products by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Leukapheresis Products by Type (2020-2031)
 Figure 56. Global Leukapheresis Products Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Leukapheresis Products by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Leukapheresis Products by Application (2020-2031)
 Figure 59. Global Leukapheresis Products Price (US$/Unit) by Application (2020-2031)
 Figure 60. Leukapheresis Products Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Life Sciences IT Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19E17259
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Rehabilitation Evaluation Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39U17029
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Modular Healthcare Buildings Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-24Y16719
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Digital Telepathology Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0S20450
Wed Nov 12 00:00:00 UTC 2025

Add to Cart